NVO is performing well despite The Orange Man's threats

NVO is performing well today despite Trump's threats regarding tariffs and the increasing risk of war and global conflict. To me this shows insane bullish momentum and that most of the sellers are out by this point. I can't believe that the Wegovy Pill wasn't priced in AT ALL, like what? It was obvious that the pill was going to be 1. Approved (95%+) 2. A huge success (maybe 80%+?, sounds like a reasonable guess) Now with several news up ahead such as Wegovy Plus approval in the US, Wegovy Pill approval in UK and EU, Wegovy Plus approval in EU, There seems to be loads of runway left. Mid Term (1-4 years) I still see Eli Lilly being the dominant player as Retatrutide completely crushes all other drugs except for Amycretin which hasn't even started phase 3. Lillys pill will also be a good opponent to Wegovy Pill due to no food restrictions, Now, my real question here is: With all the positive news coming within 2 weeks - 6 months from now, If NVO can pull off a positive Q4 result the stock will go to $80+, But how likely is that? There's a lot of uncertainty right now regarding how the price changes in Q4 has affected volume, revenue and margins, does anyone have any insights in this matter? My personal opinion is to wait for Wegovy Plus approval (should happen within 2 week from now but you never know) and sell parts of my holdings after that but before the earnings report. And even if the approval doesnt happen before the report, still unload a big chunk of my holdings at a currently 15-20% gain, to reduce risk. But if anyone has any insights / thoughts regarding how the price changes in Q4 has affected their numbers, please let me know your thoughts!